C
TBPH icon

Covestor’s Theravance Biopharma TBPH Stock Holding History

Covestor’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2K Buy
89
+68
+324% +$1.13K ﹤0.01% 1995
2026
Q1 		$0 Sell
21
-12
-36% -$212 ﹤0.01% 2755
2025
Q4 		$1K Buy
+33
New +$547 ﹤0.01% 2171
2024
Q4 		– Sell
-31
Closed – – 2728
2024
Q3 		$0 Sell
31
-31
-50% -$269 ﹤0.01% 2752
2024
Q2 		$1K Buy
62
+18
+41% +$162 ﹤0.01% 2128
2024
Q1 		$0 Buy
44
+17
+63% +$158 ﹤0.01% 2724
2023
Q4 		$0 Buy
27
+11
+69% +$111 ﹤0.01% 2702
2023
Q3 		$0 Sell
16
-2
-11% -$19 ﹤0.01% 2699
2023
Q2 		$0 Buy
+18
New +$199 ﹤0.01% 2636

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Covestor's TBPH Position: Q2 2026 in Review

Covestor increased its Theravance Biopharma (TBPH) stake by 324% in Q2 2026, buying an estimated $1.13K and bringing the position to 89 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1995.

Covestor first reported a position in TBPH in Q2 2023 and has held it in 9 quarters since. 180 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Covestor held 89 shares of Theravance Biopharma worth $2K as of Q2 2026.
  • Covestor bought 68 Theravance Biopharma shares in Q2 2026, an estimated $1.13K.
  • Theravance Biopharma made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #1995 holding.
  • Covestor first reported a position in Theravance Biopharma in Q2 2023 and has held it in 9 quarters since.
  • 180 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.